A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Several experts said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Removal
Based on TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or administering at residence.
Within minutes of entering one community, a seller shared contact information, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has already seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to potentially significant medical dangers”.
